HIV/AIDS Diagnostics

Rapid HIV test is in use by U.S.-based teaching hospitals

Published in Cancer Weekly, March 15th, 2005

MedMira Inc. (MedMira) (MMIRF) announced that Stanford Medical University, Duke Medical University and Johns Hopkin's Medical Research University are currently using MedMira's U.S. Food and Drug Administration (FDA)-approved Reveal G2 Rapid HIV-1 Antibody Test's (Reveal G2) in their central labs.

These leading medical research universities have chosen Reveal G2 over other FDA- approved rapid HIV tests after routine evaluations. A recently released report by Stanford and Duke Universities shows the cost benefits of increased national HIV testing in the United States.

MedMira had announced previously that Reveal G2 was the number one choice for U.S....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-03-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry